Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

ACPs to lead gene therapies in haemophilia market growth

ACPs to lead gene therapies in haemophilia market growth

BioMarin’s ValRox, which is expected to launch as early as 2020, and Spark Therapeutics’ SPK-8011 for haemophilia A, and uniQure’s AMT-061 and Pfizer/Spark Therapeutics’ SPK-9001 ... Therefore, first-to-market advantage will drive commercial

New results back Sangamo, UniQure haemophilia gene therapies

New results back Sangamo, UniQure haemophilia gene therapies The two firms are competing with BioMarin and Roche/Spark to bring gene therapies for haemophilia A to market, which could free patients with the disease from having to take regular ... It’s a case of so far, so good with SB-525 as Sangamo and Pfizer

Creating the Childhood Dementia Coalition and Platform

by Portland PR Ltd for BioMarin. Childhood dementia is a devastating disease, with parents watching their children gradually lose the ability to speak, see and walk. ... Creating the Childhood Dementia Coalition and Platform - by Portland PR Ltd for

Driving Awareness with the Dementia Strikes Children Too Campaign

The campaign by Portland PR and BioMarin employed targeted location based advertising very well, with striking visuals and measurable outcomes. ... Driving Awareness with the Dementia Strikes Children Too Campaign - by Portland PR for BioMarin.

Hidden MS

for BioMarin. ... Creating the Childhood Dementia Coalition and Platform by Portland PR Ltd - for BioMarin.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics